Superdisintegrants Market Worth 416.5 Million USD by 2021

The report "Superdisintegrants Market by Product (Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resins) Application (Tablets, Capsules) Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.


Browse 135 market data tables with 42 figures spread through 174 pages and in-depth TOC on "Superdisintegrants Market


Early buyers will receive 10% customization on this report.

This report studied the global superdisintegrants market during the forecast period of 2016 to 2021. The global superdisintegrants market is expected to grow at a CAGR of 7.8% during the forecast period, to reach USD 416.5 Million by 2021. Growth in this market is attributed to factors such as growing population of geriatric and pediatric patients, the growing generic drugs market, and emergence of new superdisintegrants for the pharmaceutical industry. However, factors such as declining R&D expenditures in the development of new superdisintegrants may hinder the growth of this market to a certain extent.

The global superdisintegrants market is segmented by product type, application, therapeutic area, and geography. This report also discusses the key drivers, restraints, opportunities, and challenges for this market. On the basis of product type, the market is primarily segmented into natural superdisintegrants, synthetic superdisintegrants, and others. The synthetic superdisintegrants market is further sub-segmented into modified starch, crospovidone, modified cellulose, ion exchange resins, and calcium silicates. On the other hand, the market based on application is segmented into tablets and capsules. The market by therapeutic area is segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, cardiovascular diseases, haematological diseases, and inflammatory diseases.

In 2015, the synthetic superdisintegrant market segment accounted for the largest share of the global superdisintegrants market. This is majorly attributed to the widespread use of excipients such as sodium starch glycolate, and crospovidone in orally and fast disintegrating tablets. Rising incidences of cardiovascular diseases, neurological diseases, and other related diseases are further expected to drive the demand of fast disintegrating tablets, in-turn driving demand of superdisintegrants during the forecast period.

Talk to Our Research Analysts for More Info@

On the basis of region, the superdisintegrants market is broadly segmented into North America, Europe, Asia-Pacific, and Rest of the World. Increasing investments in the development of novel oral dosage forms and constant efforts dedicated towards providing superior quality and compliant products in the market space are major factors that are expected to drive the growth of the market share for superdisintegrants in North America and Europe. However, Asia-Pacific region is expected to grow at the highest CAGR, owing to increasing healthcare spending, growing health awareness, rising healthcare infrastructure and increasing outsourcing of excipient manufacturing to Asian countries, such as India and China.

Get The Sample Copy Of This Report:


Some of the major players operating in the global superdisintegrants market include Ashland, Inc. (U.S.), BASF SE (Germany), FMC Corporation (U.S.), JRS Pharma (Germany), DFE Pharma (Germany), Roquette (France), The Dow Chemical Company (U.S.), Asahi Kasei Corporation (Japan), Nippon Soda Co., Ltd. (Japan), and Huber Corporation (U.S.).

Browse Related Reports:

Pharmaceutical Excipients Market by Products (Organic chemicals, Inorganic Chemicals), Functionality (Fillers, Binders, Lubricants, Preservatives), & by Route of Administration (Oral, Topical, Parenteral, Others) - Global Forecast to 2019


Active Pharmaceutical Ingredient Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology) - Global Forecast to 2020


About MarketsandMarkets:

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.


M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.


We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.


Subscribe Reports from Healthcare Domain @


Mr. Rohan

Unit No. 802, 8th Floor, 

Tower - 7, Magarpatta City SEZ,

Hadapsar, Pune – 411013, 

Maharashtra, India.

Tel: +1-888-6006-441.

Visit MarketsandMarkets Blog @

Connect with us on LinkedIn @